For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Arbor Biotechnologies, Inc.

Calculating rank

USPTO Granted Patents = 27

EPO Patents = 2

Trademarks = 1

Forward Citations = 35

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

David Arthur Scott (21 out of 34 patents)

David R Cheng (20 out of 21 patents)

Winston X Yan (20 out of 30 patents)

4. Shaorong Chong (10 out of 14 patents)

5. Pratyusha Hunnewell (6 out of 6 patents)

6. Quinton Norman Wessells (6 out of 6 patents)

7. Noah Michael Jakimo (5 out of 5 patents)

8. Tia Marie Ditommaso (5 out of 5 patents)

9. Tia M DiTommaso (4 out of 4 patents)

10. Sejuti Sengupta (3 out of 3 patents)

11. Jeffrey Raymond Haswell (3 out of 3 patents)

12. Brendan Jay Hilbert (3 out of 3 patents)

13. Anthony James Garrity (3 out of 3 patents)

14. Wei-Cheng Lu (2 out of 2 patents)

15. Lauren E Alfonse (2 out of 2 patents)

Core Competencies:

CRISPR

Gene Editing

Nuclease

Polypeptide

RNA Guide

Transposon Systems

Targeting Enzymes

Compositions

Cas12i

Variants

Hydroxyacid Oxidase

Lactate Dehydrogenase

27 patents: Sort by Forward Citations

1. 12774457 - GENE EDITING SYSTEMS COMPRISING AN RNA GUIDE TARGETING HYDROXYACID OXIDASE 1 (HAO1) AND USES THEREOF (2026-10-27),

2. 12747457 - COMPOSITIONS COMPRISING A CAS12I POLYPEPTIDE AND USES THEREOF (2026-09-29),

3. 12716060 - NOVEL CRISPR-ASSOCIATED SYSTEMS AND COMPONENTS (2026-08-25),

4. 12655421 - NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS (2026-06-16),

5. 12655404 - NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS (2026-06-16),

6. 12553045 - Crispr DNA targeting enzymes and systems (2026-02-17),

7. 12522812 - NOVEL CRISPR-ASSOCIATED SYSTEMS AND COMPONENTS (2026-01-13),

8. 12460203 - CRISPR RNA targeting enzymes and systems and uses thereof (2025-11-04),

9. 12460190 - CRISPR DNA targeting enzymes and systems (2025-11-04),

10. 12344870 - Compositions comprising a CRISPR nuclease and uses thereof (2025-07-01),

11. 12195770 - CRISPR DNA and RNA targeting enzymes and systems (2025-01-14),

12. 12054754 - CRISPR-associated transposon systems and components (2024-08-06),

13. 11976308 - CRISPR DNA targeting enzymes and systems (2024-05-07),

14. 11946045 - Compositions comprising a variant polypeptide and uses thereof (2024-04-02),

15. 11939607 - Gene editing systems comprising an RNA guide targeting lactate dehydrogenase a (LDHA) and uses thereof (2024-03-26),

Company Overview

Arbor Biotechnologies, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of innovative gene editing technologies. The organization focuses on harnessing the power of CRISPR and other advanced molecular tools to enable precise modifications in genetic material. Arbor's research aims to address challenges in various fields, including agriculture, healthcare, and environmental sustainability, by providing solutions that enhance genetic engineering capabilities and promote scientific advancements.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

27 Patents

#100 in Cambridge, MA

#740 in Massachusetts

#12,432 in US

#24,046 in the World

Cambridge, MA, United States of America

Arbor Biotechnologies, Inc.

Forward Citations = 35

18 inventors:

David Arthur Scott (21 out of 34 patents)

David R Cheng (20 out of 21 patents)

Winston X Yan (20 out of 30 patents)

4. Shaorong Chong (10 out of 14 patents)

5. Pratyusha Hunnewell (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Arbor Biotechnologies, Inc.. Retrieved from https://idiyas.com/company/arbor-biotechnologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…